Part 2 MRCOG: Single Best Answer Questions 1st Edition


Part 2 MRCOG: SBA Questions contains invaluable preparation and practice for candidates undertaking the Royal College of Obstetricians and Gynaecologists Part 2 MRCOG examination. It contains 400 practice questions written by a highly experienced team of MRCOG question writers, alongside detailed answers referencing each question to either an RCOG, NICE or WHO guideline, or an article in the professional journal ‘The Obstetrician & Gynaecologist’. This will enable candidates to understand the reasoning and knowledge base behind the question, as well as giving them a clear reference should they wish to read further around the subject.

The first part of the book introduces and explains the new format of the Part 2 MRCOG exam, giving insightful advice on the skills required to write a good SBA question.  The second part of the book contains chapters matched to the 15 of the 19 modules of the core curriculum, giving a comprehensive range of questions and answers with detailed explanations and references. For anyone preparing for the Part 2 MRCOG exam, this book will provide extensive and comprehensive practice and guidance from an expert author team.


[amazon template=iframe image2&asin=1119160618]


Critical Care Manual of Clinical Procedures and Competencies


[amazon template=iframe image2&asin=1405122528]

This manual is aimed at all healthcare practitioners, from novice to expert, who care for the critically ill patient, recognising that different disciplines contribute to the provision of effective care and that essential knowledge and skills are shared by all practitioners. It provides evidence-based guidelines on core critical care procedures and includes a comprehensive competency framework and specific competencies to enable practitioners to assess their abilities and expertise. Each chapter provides a comprehensive overview, beginning with basic principles and progressing to more complex ideas, to support practitioners to develop their knowledge, skills and competencies in critical care.


Prosthodontics at a Glance 1st Edition


[amazon template=iframe image2&asin=1405176911]

Prosthodontics at a Glance is a title in the popular At A Glance series and focuses on prosthodontics from diagnostics through treatment to post-operative maintenance. It is an ideal companion for all students of dentistry, clinicians and members of the dental team with an interest in prosthodontics.


Pocket Prescriber Emergency Medicine 1st Edition


[amazon template=iframe image2&asin=1444176641]

Drug prescribing errors are a common cause of hospital admission, and adverse reactions can have devastating effects, some even fatal. Pocket Prescriber Emergency Medicine is a concise, up-to-date prescribing guide containing all the “must have” information on a vast range of drugs that staff from junior doctors to emergency nurses, nurse prescribers, paramedics and other pre-hospital providers may encounter in the emergency setting.

Key features:

• A–Z list of over 500 of the most commonly prescribed drugs with each entry containing the key prescribing information

• Safety issues, warnings, drug errors and adverse effects

• Practical guidance on drug selection, plus protocols and resuscitation guidelines

• Advice and reference information for complicated prescriptions

• Concise management summaries for common medical and surgical emergencies

• Essential advice for pain relief―from acute pain management to procedural sedation

• Clinically useful reminders of key facts from basic pharmacology to acute poisoning syndromes

Pocket Prescriber Emergency Medicine supplies all your information needs concerning commonly prescribed drugs at a glance, enabling on-the-spot decision-making to provide the highest standard of care whilst mitigating prescribing errors.


Benefit-Risk Assessment Methods in Medical Product Development


[amazon template=iframe image2&asin=1482259362]

Benefit–Risk Assessment Methods in Medical Product Development: Bridging Qualitative and Quantitative Assessments provides general guidance and case studies to aid practitioners in selecting specific benefit–risk (B–R) frameworks and quantitative methods. Leading experts from industry, regulatory agencies, and academia present practical examples, lessons learned, and best practices that illustrate how to conduct structured B–R assessment in clinical development and regulatory submission.

The first section of the book discusses the role of B–R assessments in medicine development and regulation, the need for both a common B–R framework and patient input into B–R decisions, and future directions. The second section focuses on legislative and regulatory policy initiatives as well as decisions made at the U.S. FDA’s Center for Devices and Radiological Health. The third section examines key elements of B–R evaluations in a product’s life cycle, such as uncertainty evaluation and quantification, quantifying patient B–R trade-off preferences, ways to identify subgroups with the best B–R profiles, and data sources used to assist B–R assessment. The fourth section equips practitioners with tools to conduct B–R evaluations, including assessment methodologies, a quantitative joint modeling and joint evaluation framework, and several visualization tools. The final section presents a rich collection of case studies.

With top specialists sharing their in-depth knowledge, thought-provoking considerations, and practical advice, this book offers comprehensive coverage of B–R evaluation methods, tools, and case studies. It gives practitioners a much-needed toolkit to develop and conduct their own B–R evaluations.


Bayesian Designs for Phase I–II Clinical Trials (Chapman & Hall/CRC Biostatistics Series) 1st Edition


[amazon template=iframe image2&asin=1498709559]

Reliably optimizing a new treatment in humans is a critical first step in clinical evaluation since choosing a suboptimal dose or schedule may lead to failure in later trials. At the same time, if promising preclinical results do not translate into a real treatment advance, it is important to determine this quickly and terminate the clinical evaluation process to avoid wasting resources.

Bayesian Designs for Phase I–II Clinical Trials describes how phase I–II designs can serve as a bridge or protective barrier between preclinical studies and large confirmatory clinical trials. It illustrates many of the severe drawbacks with conventional methods used for early-phase clinical trials and presents numerous Bayesian designs for human clinical trials of new experimental treatment regimes.

The first two chapters minimize the technical language to make them accessible to non-statisticians. These chapters discuss the severe drawbacks of the conventional paradigm used for early-phase clinical trials and explain the phase I–II paradigm for optimizing dose, or more general treatment regimes, based on both efficacy and toxicity. The remainder of the book covers a wide variety of clinical trial methodologies, including designs to optimize the dose pair of a two-drug combination, jointly optimize dose and schedule, identify optimal personalized doses, optimize novel molecularly targeted agents, and choose doses in two treatment cycles.

Written by research leaders from the University of Texas MD Anderson Cancer Center, this book shows how Bayesian designs for early-phase clinical trials can explore, refine, and optimize new experimental treatments. It emphasizes the importance of basing decisions on both efficacy and toxicity.


Infection Control for Advanced Practice Professionals


[amazon template=iframe image2&asin=1605950602]

Presents best practices for infection prevention and control in advanced practice Emphasizes team approach for infection control Case study provided for each chapter

——————————————————————————– This professional reference combines research on the best practices for infection control in clinical settings with essential information for advanced practice nurses and physician assistants. The book is organized by healthcare settings, and the coverage ranges from small practice offices to large hospitals and medical institutions. Each chapter is prefaced by a case study which is then incorporated into the theoretical material of the chapter as a continuing illustration. This format provides a reader-friendly instructional resource for advanced practice certifications and staff development.

From the Foreword

“At last is published a long-needed text for advanced practice nurses (APNs), providing them with the information essential to the care of essentially every patient they will encounter. Infection Control for Advanced Practice Professionals fills a void in the literature and recognizes the importance of a team approach to the prevention of infections in the variety of care settings in which APNs are practicing. The book is particularly timely and relevant because it appropriately places infection prevention solidly within the larger patient safety movement and affirms that preventing infections is everybody’s concern. In acute care settings, for example, infection control has occasionally been relegated to the infection prevention specialist (e.g., infection control nurse or hospital epidemiologist) or the infection control committee. This has shown to be ineffective in any setting. It is those who “touch” the patients and oversee their care who must assume the responsibility for preventing untoward events such as infections. While not all infections are preventable, there is indeed room for improvement. This comprehensive reference is a first and essential step in that direction!”

Elaine Larson, PhD, RN, FAAN, CIC Anna C. Maxwell Professor of Nursing Research Associate Dean for Research School of Nursing Professor of Epidemiology Joseph Mailman School of Public Health Columbia University Editor, American Journal of Infection Control


Cultural Psychiatry (Advances in Psychosomatic Medicine, Vol. 33) 1st Edition


[amazon template=iframe image2&asin=3318023949]

Cultural Psychiatry with emphasis on its impact on etio-pathogenesis, diagnosis, clinical practice, preventive and research activities are topics discussed in this publication which give readers a general conceptual perspective of this field. Cultural aspects of psychiatric diagnosis in DSM-5 in particular and the current status of Cultural Psychiatry in European countries are discussed. Of unique importance to the field of psychosomatics are the reviews on so-called culture-bound syndromes and somatization and culture. Ethnopsychopharmacology, pharmacogenomics, current and future research perspectives in Cultural Psychiatry and bioethical dimensions of cultural psychosomatics are also reviewed. The volume closes with an epilogue and conclusions resulting from the examined topics. Psychiatrists, psychologists, social scientists and other mental health professionals involved in clinical practice and research groups as well as trainees and students will find that this publication provides a cogent perspective of current practice and research issues about a field that has enormous clinical relevance and which, until recently, has been systematically neglected.


1 459 460 461 462 463 597